Some $254.7m spent on COVID-19 vaccination| MENAFN.COM

Friday, 28 January 2022 09:51 GMT

Some $254.7m spent on COVID-19 vaccination


(MENAFN- AzerNews)

By Ayya Lmahamad

Azerbaijan has spent AZN 433 million ($254.7M) for vaccination against coronavirus so far, Prime Minister Ali Asadov said at the parliament's plenary session on December 3.

He noted that the state budget for 2022 provides appropriate funds for the vaccination.

The nationwide vaccination is free and on a voluntary basis and is in line with the“Strategy of vaccination against COVID-19 in Azerbaijan for 2021-2022”.

The country started vaccinating citizens using China's Sinovac on January 18, Vaxzevria vaccine produced by AstraZeneca on May 3, Russia's Sputnik V on May 18, and U.S-produced Pfizer on June 7. The country started offering COVID-19 vaccination to citizens aged over 18 from May 10.

At the same time, as of August 9, Azerbaijan started issuing vaccination exemption certificates for citizens with contraindications to coronavirus vaccines approved for use in the country.

Totally, so far, 10,604,976 citizens have been vaccinated, 5,087,717 of whom received the first dose of the vaccine, 4,578,492 people - the second dose, 938,767 people - the third dose.

The country confirmed its first COVID-19 case on February 28, 2020. The country introduced a special quarantine regime on March 25 and took a number of measures to fight COVID-19 in the country.

--

Ayya Lmahamad is AzerNews' staff journalist, follow her on Twitter: @AyyaLmahamad

Follow us on Twitter @AzerNewsAz

  • #COVID-19 VACCINATION
  • #CORONAVIRUS IN AZERBAIJAN
  • #ALI ASADOV

MENAFN03122021000195011045ID1103299725


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.